Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on May 7, 2013. The filing documents the results of the Company's annual meeting of stockholders held on that date, specifically focusing on the approval of amendments to executive compensation plans and the election of directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a corporate governance report regarding stockholder votes and plan amendments.
Material Changes and Corporate Actions
Stockholders approved several material changes to the Company's governance and compensation structures:
- Executive Performance Incentive Plan (EPIP): The plan was amended to extend its term to May 31, 2020, and to include two new performance measures: quality measures and regulatory compliance measures. This amendment satisfies the requirement under Section 162(m) of the Internal Revenue Code for stockholder approval every five years.
- 2009 Stock Incentive Plan: The plan was amended to increase the number of shares available for issuance by 3.7 million. Additionally, the ratio by which full value awards count against the share reserve was increased from 2:1 to 2.37:1, and the plan term was extended to May 31, 2020.
- Director Elections: Nine directors were elected for one-year terms.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2013.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on future business performance. It does not disclose new risks or contingencies beyond the standard governance updates. The primary focus is on the successful ratification of executive compensation mechanisms.
Key Facts for Investor Verification
- Verify the specific terms of the new "quality" and "regulatory compliance" performance measures added to the EPIP in the full text of Exhibit 10.1.
- Review the impact of the increased share reserve count ratio (2.37:1) on future dilution under the 2009 Stock Incentive Plan.
- Note the significant "Against" vote on Proposal No. 5 (Amended 2009 Plan), where approximately 15.8 million shares voted against the proposal compared to 108.2 million in favor.
- Confirm the total number of shares available for issuance under the amended 2009 Plan by adding the 3.7 million share increase to the prior balance.